Reaction

Hypophosphataemic Osteomalacia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 259 reports · 6 co-occurring drugs

As of the last recalculation, Hypophosphataemic Osteomalacia appears in 259 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is TENOFOVIR DISOPROXIL FUMARATE TABLETS (PRR 223.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Tenofovir Disoproxil Fumarate Tablets22223.7224.2
Tenofovir Disoproxil Fumarate38108.1108.2
Lamivudine Oral2587.887.9
Lamivudine2571.971.9
Entecavir964.164.2
Iron Sucrose651.851.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.